Weiss Multi Strategy Advisers LLC Vertex Pharmaceuticals Inc Put Options Transaction History

Weiss Multi Strategy Advisers LLC

3 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2022 May 16, 2022	BUY	$221.42 - $260.97 $6.2 Million - $7.31 Million	28,000 Added 1400.0%	30,000 $7.83 Million
Q4 2021 Feb 14, 2022	SELL	$177.01 - $223.45 $531,030 - $670,350	-3,000 Reduced 60.0%	2,000 $439,000
Q2 2021 Aug 16, 2021	BUY	$187.49 - $221.1 $937,450 - $1.11 Million	5,000 New	5,000 $1.01 Million

1,716

225M

1.19M

1.56M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $129B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Weiss Multi Strategy Advisers LLC, based on Form 13F filings with the SEC.

Stay updated on Weiss Multi Strategy Advisers LLC with notifications on news.